Display options
Share it on

Degener Neurol Neuromuscul Dis. 2014 Dec 09;4:153-162. doi: 10.2147/DNND.S73506. eCollection 2014.

Optical coherence tomography for retinal imaging in multiple sclerosis.

Degenerative neurological and neuromuscular disease

Hanna Zimmermann, Timm Oberwahrenbrock, Alexander U Brandt, Friedemann Paul, Jan Dörr

Affiliations

  1. NeuroCure Clinical Research Center.
  2. Department of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  3. Clinical and Experimental Multiple Sclerosis Research Center.

PMID: 32669908 PMCID: PMC7337265 DOI: 10.2147/DNND.S73506

Abstract

Visual disturbances caused by inflammatory and demyelinating processes of the visual system, mainly in the optic nerve, are a common symptom in multiple sclerosis (MS). Optical coherence tomography (OCT) is a tool that is increasingly used for quantifying retinal damage in MS and other neurologic diseases. Based on spectral interferometry, it uses low-coherent infrared light to generate high-resolution spatial images of the retina. The retinal nerve fiber layer (RNFL) consists of unmyelinated axons that form the optic nerve, and thus represents a part of the central nervous system. OCT allows for noninvasive measurements of RNFL thickness in micrometer resolution. With the help of OCT, researchers have managed to demonstrate that eyes of MS patients show distinct RNFL thinning after an event of acute optic neuritis in MS, and even subclinical damage in eyes with no previous optic neuritis. OCT is also a useful tool in terms of providing a differential diagnosis of MS toward, for example, neuromyelitis optica, a disease that usually shows stronger retinal thinning, or Susac syndrome, which is characterized by distinct patchy thinning of the inner retinal layers. RNFL thinning is associated with magnetic resonance imaging-derived measurements of the brain, such as whole-brain atrophy, gray and white matter atrophy, and optic radiation damage. These features suggest that OCT-derived retinal measurements are a complement for measuring central nervous system neurodegeneration in the context of clinical trials - for example, with neuroprotective substances.

© 2014 Zimmermann et al.

Keywords: Susac syndrome; multiple sclerosis; neuromyelitis optica; optic neuritis; retinal nerve fiber layer; visual function

References

  1. J Neuroophthalmol. 2013 Sep;33(3):220-4 - PubMed
  2. Invest Ophthalmol Vis Sci. 2014 Feb 18;55(2):952-61 - PubMed
  3. Ophthalmology. 2006 Feb;113(2):324-32 - PubMed
  4. Ann Neurol. 2012 Aug;72(2):199-210 - PubMed
  5. Nat Rev Neurol. 2014 Aug;10(8):447-58 - PubMed
  6. Neurology. 2013 Apr 9;80(15):1406-14 - PubMed
  7. Brain. 2012 Jun;135(Pt 6):1786-93 - PubMed
  8. Mult Scler. 2010 Jul;16(7):893-6 - PubMed
  9. Eur J Neurol. 2013 Aug;20(8):1170-6 - PubMed
  10. Trials. 2012 Feb 08;13:15 - PubMed
  11. J Neurol Sci. 2010 Dec 15;299(1-2):86-91 - PubMed
  12. J Neurol Sci. 2009 Jul 15;282(1-2):96-105 - PubMed
  13. N Engl J Med. 2006 Mar 23;354(12):1273-80 - PubMed
  14. Neurology. 2014 Jul 1;83(1):73-7 - PubMed
  15. PLoS One. 2011;6(7):e23024 - PubMed
  16. J Neuroophthalmol. 2013 Sep;33(3):213-9 - PubMed
  17. J Neurol Neurosurg Psychiatry. 2009 Jul;80(7):767-72 - PubMed
  18. J Neurol Neurosurg Psychiatry. 2014 Jul;85(7):782-9 - PubMed
  19. Neurology. 1994 Apr;44(4):591-3 - PubMed
  20. Brain. 2009 Mar;132(Pt 3):628-34 - PubMed
  21. J Neurol Sci. 2012 Nov 15;322(1-2):35-40 - PubMed
  22. Neurology. 2009 Jul 28;73(4):302-8 - PubMed
  23. Mult Scler Int. 2011;2011:869814 - PubMed
  24. Brain. 2013 Jul;136(Pt 7):e239 - PubMed
  25. Lancet Neurol. 2010 Sep;9(9):921-32 - PubMed
  26. Ann Neurol. 2005 Sep;58(3):383-91 - PubMed
  27. Clin Exp Immunol. 2014 May;176(2):149-64 - PubMed
  28. PLoS One. 2012;7(6):e38741 - PubMed
  29. J Neuroinflammation. 2014 Mar 08;11:46 - PubMed
  30. Lancet. 2008 Oct 25;372(9648):1502-17 - PubMed
  31. Brain. 2012 Feb;135(Pt 2):521-33 - PubMed
  32. Ophthalmology. 2013 Feb;120(2):387-94 - PubMed
  33. Mult Scler. 2014 Sep;20(10):1299-301 - PubMed
  34. Neurophysiol Clin. 2010 Jun;40(3):129-35 - PubMed
  35. Lancet Neurol. 2014 Jan;13(1):83-99 - PubMed
  36. Mult Scler. 2014 Sep;20(10):1331-41 - PubMed
  37. J Neurol Neurosurg Psychiatry. 1963 Oct;26:402-9 - PubMed
  38. Mult Scler. 2013 Dec;19(14):1887-95 - PubMed
  39. Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4412-7 - PubMed
  40. Prog Retin Eye Res. 2008 Jan;27(1):45-88 - PubMed
  41. Neurodegener Dis Manag. 2014;4(2):165-76 - PubMed
  42. Ophthalmology. 2012 Jun;119(6):1250-7 - PubMed
  43. Arch Neurol. 2009 Nov;66(11):1373-7 - PubMed
  44. PLoS One. 2011 Apr 06;6(4):e18019 - PubMed
  45. BMC Neurol. 2014 Feb 20;14:31 - PubMed
  46. Neurology. 2007 Oct 16;69(16):1603-9 - PubMed
  47. Ophthalmology. 2007 May;114(5):921-6 - PubMed
  48. Neurology. 2010 Apr 27;74 Suppl 3:S16-23 - PubMed
  49. Mov Disord. 2014 Aug;29(9):1163-70 - PubMed
  50. Eur Radiol. 2015 Jan;25(1):122-31 - PubMed
  51. Invest Ophthalmol Vis Sci. 1999 Oct;40(11):2520-7 - PubMed
  52. J Neurol Sci. 2009 Jun 15;281(1-2):74-9 - PubMed
  53. Br J Ophthalmol. 2003 Jul;87(7):899-901 - PubMed
  54. J Neurol Sci. 2013 Dec 15;335(1-2):182-5 - PubMed
  55. PLoS One. 2011 Apr 08;6(4):e18132 - PubMed
  56. Ophthalmology. 2009 Jun;116(6):1119-24 - PubMed
  57. Mult Scler. 2013 Apr;19(4):443-50 - PubMed
  58. Neurology. 2009 Mar 24;72(12):1077-82 - PubMed
  59. Science. 1991 Nov 22;254(5035):1178-81 - PubMed
  60. Mult Scler. 2008 Aug;14(7):988-91 - PubMed
  61. J Neurol Neurosurg Psychiatry. 2015 Apr;86(4):419-24 - PubMed
  62. Mult Scler. 2012 Jul;18(7):991-9 - PubMed
  63. Brain. 2011 Feb;134(Pt 2):518-33 - PubMed
  64. Brain. 2011 Nov;134(Pt 11):e193; author reply e194 - PubMed
  65. PLoS One. 2011;6(5):e19843 - PubMed
  66. Invest Ophthalmol Vis Sci. 2013 Dec 11;54(13):8095-103 - PubMed
  67. J Neurol. 2008 Oct;255(10):1555-60 - PubMed
  68. J Neurol Sci. 2008 May 15;268(1-2):12-7 - PubMed
  69. JAMA Neurol. 2013 Jan;70(1):34-43 - PubMed
  70. Invest Ophthalmol Vis Sci. 2012 Jun 26;53(7):3959-66 - PubMed
  71. Mult Scler. 2012 Oct;18(10):1422-9 - PubMed
  72. Mult Scler. 2014 Sep;20(10):1296-8 - PubMed
  73. Neurology. 2013 Jan 1;80(1):47-54 - PubMed
  74. Eur J Neurol. 2013 May;20(5):803-11 - PubMed
  75. Ann Neurol. 2010 Jun;67(6):749-60 - PubMed
  76. Neurology. 2006 May 23;66(10):1485-9 - PubMed
  77. J Alzheimers Dis. 2014;42 Suppl 3:S99-108 - PubMed
  78. Nervenarzt. 2013 Apr;84(4):483-92 - PubMed
  79. PLoS One. 2013 Aug 06;8(8):e71145 - PubMed
  80. Arch Neurol. 2008 Jul;65(7):924-8 - PubMed
  81. Nat Rev Neurol. 2009 Dec;5(12):683-8 - PubMed
  82. Ann Neurol. 2014 Jan;75(1):98-107 - PubMed
  83. Invest Ophthalmol Vis Sci. 2014 Sep 04;55(10):6127-31 - PubMed
  84. Lancet Neurol. 2012 Nov;11(11):963-72 - PubMed
  85. Retina. 2013 Nov-Dec;33(10):2133-8 - PubMed
  86. J Neuroophthalmol. 2013 Dec;33(4):322-9 - PubMed
  87. Mult Scler Int. 2012;2012:530305 - PubMed
  88. Br J Ophthalmol. 2012 Jan;96(1):62-7 - PubMed
  89. Mult Scler. 2011 Dec;17(12):1449-63 - PubMed
  90. Nat Rev Neurol. 2013 Jun;9(6):307-16 - PubMed
  91. Ophthalmology. 2014 Jan;121(1):142-149 - PubMed
  92. Brain. 2013 Nov;136(Pt 11):e260 - PubMed
  93. PLoS One. 2013 Jun 21;8(6):e66151 - PubMed
  94. Mult Scler. 2014 Sep;20(10):1342-7 - PubMed
  95. Mult Scler. 2012 Nov;18(11):1592-9 - PubMed
  96. Ophthalmology. 1998 Jun;105(6):1038-44 - PubMed
  97. Curr Treat Options Neurol. 2008 Jan;10(1):67-74 - PubMed
  98. Clin Neurol Neurosurg. 2010 Oct;112(8):647-52 - PubMed
  99. Brain. 2010 Jun;133(Pt 6):1591-601 - PubMed
  100. J Neurol. 2007 Nov;254(11):1595-6 - PubMed
  101. Neurology. 2007 May 1;68(18):1488-94 - PubMed

Publication Types